Phio Pharmaceuticals
PHIO
#10187
Rank
S$16.75 M
Marketcap
S$1.52
Share price
-5.20%
Change (1 day)
-15.61%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -S$10.43 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$9.16 Million, an increase over its 2023 earnings that were of -S$13.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$10.43 Million13.83%
2024 -S$9.16 Million-33.96%
2023 -S$13.87 Million-5.7%
2022 -S$14.71 Million-13.6%
2021 -S$17.02 Million51.09%
2020 -S$11.27 Million-1.28%
2019 -S$11.42 Million21.03%
2018 -S$9.43 Million-53.1%
2017 -S$20.11 Million74.49%
2016 -S$11.53 Million-12.02%
2015 -S$13.1 Million16.17%
2014 -S$11.28 Million-57.95%
2013 -S$26.81 Million62.45%
2012 -S$16.5 Million0.87%
2011 -S$16.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.26 Million 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA